Image

Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation

Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

To look at the effect of a recipient's ancestry and socio-economic status on their choice of bone marrow transplantation donor cells and their chance of receiving genetically similar (allogeneic) bone marrow cells versus cells that are not genetically similar (allograft).

Description

Primary Objectives To prospectively evaluate graft options and choice of donor by patient ancestry and SES for allograft candidates at MDACC.

Secondary Objectives

  • To prospectively evaluate time to transplant for allograft candidates at MDACC.
  • To evaluate treatment-related mortality for allograft candidates at MDACC.
  • To assess overall survival for allograft candidates at MDACC.
  • To prospectively evaluate receipt of preferred unrelated donor for allograft recipients at MDACC.
  • To evaluate receipt of an optimal graft for allograft recipients at MDACC.

Eligibility

Inclusion Criteria:

  1. ≥ 18 years of age.
  2. Candidate for allogeneic transplantation

Exclusion Criteria:

  1. Allogeneic stem cell transplantation not medically indicated.

Study details
    Allogeneic Transplantation

NCT06450353

M.D. Anderson Cancer Center

7 August 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.